Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotero Soft/Intense Lidocaine PMCF in Facial Soft Tissue Augmentation
DRKS00031121Phase 4Completed
- Sponsor
- Merz
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of BELOTERO Soft Lidocaine and hyaluronic acid + lidocaine in dermal filler, sponsored by Merz. Started Mar 2023; status: completed.
02
Drugs
BELOTERO Soft Lidocainehyaluronic acid + lidocaine
03
Conditions
dermal filler
Beyond the preview
Go deeper on DRKS00031121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031121.